MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Benzodiazepines"

  • 2024 International Congress

    Benzodiazepines in the Management of Restless Legs Syndrome: A Systematic Review and Meta-Analysis

    G. Bolner, H. Rodriguez, V. Xavier, A. Petry, M. da Rosa, A. Rossato, M. Felippe, T. Denicol, A. Hilbig (Porto Alegre, Brazil)

    Objective: To evaluate the efficacy and safety of benzodiazepines (BZD) as treatment for Restless Legs Syndrome (RLS), compared to placebo or other drugs. Background: RLS…
  • 2024 International Congress

    Outcomes in Patients with Parkinsonism Treated for Acute Agitation with Intravenous Benzodiazepines Compared to Parenteral Antipsychotics While Inpatient

    A. Kundrick, C. Piccinin, J. Yu, P. Clark, S. Shaffer, O. Hogue, C. Sonneborn, B. Sokola, S. Sperling, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether patients with parkinsonism and severe agitation while inpatient have better outcomes when treated with parenteral benzodiazepines instead of parenteral antipsychotics. Background:…
  • 2022 International Congress

    Alprazolam reduces freezing of gait and improves freezing-related gait measures

    A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Spinal myoclonus in secondary progressive multiple sclerosis

    N. Raisa, B. Munir, S. Rianawati (Malang, Indonesia)

    Objective: We report a rare case of secondary progressive multiple sclerosis with one of the manifestation was spinal myoclonus. Background: Myoclonus is a sudden and…
  • MDS Virtual Congress 2021

    Predictors of antidepressant and benzodiazepine treatment in Parkinson’s disease

    G. Gentile, G. Zanotelli, L. Weis, R. Biundo, F. Sambataro, A. Antonini (Padua, Italy)

    Objective: To assess the prevalence of antidepressant and benzodiazepine (BDZ) treatment in Parkinson’s disease (PD), to analyze treatment with respect to altered mood indication, and…
  • 2019 International Congress

    Potential treatment considerations for refractory REM behavior disorder

    J. Nguyen, K. Papesh (Las Vegas, NV, USA)

    Objective: A meta-analysis of alternative treatment therapies for refractory REM behavior disorder. Background: Parkinson’s disease is a neurodegenerative syndrome that affects motor and non-motor functions.…
  • 2019 International Congress

    MOVEMENT DISORDERS FEATURES ASSOCIATED WITH WEST SYNDROME

    FS. Ngoungoure Halima, AM. Magnerou, CV. Hotcho Nganhou, M. Ndiaye, AG. Diop (Douala, Cameroon)

    Objective: To describe the clinical, therapeutic and outcome features of movement disorders (MD) observed in children with West Syndrome (WS) at the Neurology Department of…
  • 2016 International Congress

    Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

    R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

    Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…
  • 2016 International Congress

    Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?

    F. Richter, C. Bode, C. Spröte, A. Bauer, A. Richter (Leipzig, Germany)

    Objective: To further define the pathophysiology of the reduction of striatal interneurons in an animal model of dystonia and to develop novel therapeutic strategies targeting…

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley